Overview of CRE mutations, amplifications, and losses associated with altered target gene expression in DLBCL and FL. (A) Genome-wide mutation burden for each tumor. (B) Occurrence of SNVs in the TPRG1 CRE. (C) Occurrence of amplifications and losses at CREs associated with altered target gene expression. (D) Disease type and the cell of origin of each tumor. The figure was generated by using GenVisR.⁶⁰